261 related articles for article (PubMed ID: 10684836)
1. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil.
Midena E; Angeli CD; Valenti M; de Belvis V; Boccato P
Br J Ophthalmol; 2000 Mar; 84(3):268-72. PubMed ID: 10684836
[TBL] [Abstract][Full Text] [Related]
2. Conjunctival squamous cell carcinoma treated with topical 5-fluorouracil.
Midena E; Boccato P; Angeli CD
Arch Ophthalmol; 1997 Dec; 115(12):1600-1. PubMed ID: 9400803
[No Abstract] [Full Text] [Related]
3. Topical 5-fluorouracil in treating epithelial neoplasia of the conjunctiva and cornea.
Yeatts RP; Ford JG; Stanton CA; Reed JW
Ophthalmology; 1995 Sep; 102(9):1338-44. PubMed ID: 9097771
[TBL] [Abstract][Full Text] [Related]
4. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.
Parrozzani R; Frizziero L; Trainiti S; Testi I; Miglionico G; Pilotto E; Blandamura S; Fassina A; Midena E
Br J Ophthalmol; 2017 Aug; 101(8):1094-1099. PubMed ID: 27941046
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of topical 5-fluorouracil in conjunctival squamous carcinoma is associated with changes in matrix metalloproteinases and tissue inhibitor of metalloproteinases expression.
Iovieno A; Lambiase A; Moretti C; Perrella E; Bonini S
Cornea; 2009 Aug; 28(7):821-4. PubMed ID: 19574900
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of 9 squamous epithelial carcinoma in situ lesions of the conjunctiva (CIN) with mitomycin C eyedrops in cytological and DNA image cytometric control].
Cartsburg O; Kersten A; Sundmacher R; Nadjari B; Pomjanski N; Böcking A
Klin Monbl Augenheilkd; 2001 Jun; 218(6):429-34. PubMed ID: 11488009
[TBL] [Abstract][Full Text] [Related]
7. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
Chaugule SS; Park J; Finger PT
Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes.
Bakal K; Molugu S; Machakuri K; Bejjanki KM; Kapoor AG; Kaliki S
Int Ophthalmol; 2024 Jun; 44(1):251. PubMed ID: 38907750
[TBL] [Abstract][Full Text] [Related]
9. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
Shields CL; Naseripour M; Shields JA
Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
[TBL] [Abstract][Full Text] [Related]
10. Topical 5-Fluorouracil 1% as Primary Treatment for Ocular Surface Squamous Neoplasia.
Joag MG; Sise A; Murillo JC; Sayed-Ahmed IO; Wong JR; Mercado C; Galor A; Karp CL
Ophthalmology; 2016 Jul; 123(7):1442-8. PubMed ID: 27030104
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea.
Yeatts RP; Engelbrecht NE; Curry CD; Ford JG; Walter KA
Ophthalmology; 2000 Dec; 107(12):2190-5. PubMed ID: 11097594
[TBL] [Abstract][Full Text] [Related]
12. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
Rudkin AK; Dempster L; Muecke JS
Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
[TBL] [Abstract][Full Text] [Related]
13. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia.
Akpek EK; Ertoy D; Kalayci D; Hasiripi H
Cornea; 1999 Jan; 18(1):59-62. PubMed ID: 9894938
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
Venkateswaran N; Mercado C; Galor A; Karp CL
Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
[TBL] [Abstract][Full Text] [Related]
15. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
Couch SM; Custer PL
Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
[TBL] [Abstract][Full Text] [Related]
16. Assessing outcomes of topical 5-fluorouracil as primary and adjuvant therapy for squamous cell carcinoma in-situ.
Queen D; Trager MH; Fan W; Gordon ER; Samie FH
Arch Dermatol Res; 2024 May; 316(6):220. PubMed ID: 38787403
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
Bahrami B; Greenwell T; Muecke JS
Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
[TBL] [Abstract][Full Text] [Related]
18. Orbital invasion despite topical anti-metabolite therapy for conjunctival carcinoma.
Char DH; Crawford JB
Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):459-61. PubMed ID: 18193262
[TBL] [Abstract][Full Text] [Related]
19. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
20. Topical mitomycin-C for partially excised conjunctival squamous cell carcinoma.
Frucht-Pery J; Rozenman Y; Pe'er J
Ophthalmology; 2002 Mar; 109(3):548-52. PubMed ID: 11874760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
